Prof. Erika Lietzan

Professor Lietzan Publishes Essay on Supreme Court Decision in Sandoz v. Amgen

June 21st, 2017

This heavily-anticipated decision related to patent disputes between the developers of new biological medicines and the manufacturers of “biosimilar” copies of those medicines.

Professor Lietzan Named Affiliate Scholar of Center for the Protection of Intellectual Property

June 7th, 2017

Professor Erika Lietzan has been named an Affiliate Scholar at the Center for the Protection of Intellectual Property, part of George Mason University’s Antonin Scalia Law School. She is also currently the recipient of an Thomas Edison

Read More

Professor Lietzan to Attend Economics Institute for Law Professors

May 17th, 2017

Professor Erika Lietzan was selected to attend the Thirty-Third Economics Institute for Law Professors, hosted by the Henry G. Manne Program in Law and Economic Studies at the Antonin Scalia Law School at George Mason University. Professor

Read More

Professor Lietzan Files Amicus Brief with U.S. Supreme Court in Patent Case

March 24th, 2017

Professor Lietzan recently filed an amicus brief in the United States Supreme Court, in a closely-watched case involving patent litigation under the Biologics Price Competition and Innovation Act (BPCIA). The appellate court concluded that biosimilar applicants may

Read More

Professor Lietzan Quoted on Selection of FDA Commissioner

March 23rd, 2017

Professor Erika Lietzan was recently quoted in BuzzFeed News regarding President Donald Trump’s selection of Dr. Scott Gottlieb to be the next commissioner of the U.S. Food & Drug Administration. Dr. Gottlieb was deputy commissioner under President

Read More